Ocular Histoplasmosis Syndrome
2 clinical trials · Condition
◉ Watch Ocular Histoplasmosis Syndrome
| Record | Firm | Date |
|---|---|---|
| Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD (NCT01256580) | Massachusetts Eye and Ear Infirmary | 2010-08-01 |
| Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Ocular Histoplasmosis Syndrome (NCT00955630) | Retina Associates of Kentucky | 2009-08-01 |
Track Ocular Histoplasmosis Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.